100%
Skip to main content
Platform
GovTribe AI
AI-powered insights to accelerate your government contracting workflow.
MCP Server
Connect GovTribe to your AI tools.
Beacon
Find and connect with key government decision-makers.
Profiles
Federal Agencies
Federal Contract Vehicles
Federal Grant Programs
Major Defense Acquisition Programs
NAICS Categories
PSC Categories
States
Jurisdictions
NIGP Categories
UNSPSC Categories
Vendors
Enrichment By Clearbit
Reports
New Entrants
Funding Analysis
Vehicle Analysis
Groups
Capture
Pipelines
Pursuits
Alerts
Teaming
Data
Awards
Forecasts
Federal Opportunities
State & Local Opportunities
Files
Prime and Subcontractors
Activity
Search
Exports
Solutions
Use Case
Opportunity Identification
Capture Management
Competitive Intelligence
Teaming & Partner Identification
Proposal Management
Strategic Leadership
Go-to-Market Strategy
Industry
Federal Contractors
State & Local Contractors
Grant Seekers
Government Agencies
Research & Consulting
Pricing
More
About Us
Features
Get A Demo
Sign Up
Blog
User Guide
Data Model
GovTribe for Agents
Login
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Grant Awards
Project Grant R43GM134769
Award Date
8/1/19
Completion Date
7/31/20
Dollars Obligated
$150K
Overview
Activity
3
Transactions
3
Subawards
Similar Awards
Federal Agency
National Institute of General Medical Sciences
Awardee
Acpharis (E4Z3M7L7NHT3)
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Holliston, MA 01746, USA
Update #1
Update #2
SOFTWARE FOR ANTIBODY EPITOPE PREDICTION
Posted 7/22/19
5
1
Mod #
Description
ReasonForModification
Federal Obligation
Date
Not listed
SOFTWARE FOR ANTIBODY EPITOPE PREDICTION - ACCURATE EPITOPE PREDICTION IS IMPORTANT FOR THE DEVELOPMENT OF ANTIBODY-BASED THERAPIES. WHEN MULTIPLE NEW ANTIBODIES ARE DISCOVERED AGAINST THE WHOLE ANTIGEN, THEIR EPITOPES AND, THEREFORE, POTENTIAL NOVELTY AND MECHANISM OF ACTION ARE USUALLY UNKNOWN SITE-DIRECTED MUTAGENESIS, THE ROUTINE METHOD FOR EPITOPE MAPPING, REQUIRES TESTING A LARGE NUMBER OF MUTANTS SINCE ANY PART OF THE ANTIGEN CAN POTENTIALLY FORM AN EPITOPE THE GOAL OF THIS PROPOSAL IS DEVELOPING METHODOLOGY AND SOFTWARE FOR THE ACCURATE COMPUTATIONAL PREDICTION OF DISCONTINUOUS B-CELL EPITOPES BASED ON THE STRUCTURE OF AN ANTIGEN AND THE STRUCTURE OR SEQUENCE OF AN ANTIBODY. OUR STARTING POINT IS PIPER, A PROTEIN-PROTEIN DOCKING PROGRAM LICENSED BY ACPHARIS FROM BOSTON UNIVERSITY. PIPER IS THE DOCKING ENGINE IN THE SOFTWARE PACKAGES BIOLUMINATE BY SCHRODINGER AND THE CYRUSBENCH SUITE OF CYRUS BIOTECHNOLOGY, AS WELL AS IN THE PUBLIC SERVER CLUSPRO. PIPER HAS A SPECIAL OPTION FOR ANTIBODY-ANTIGEN DOCKING, AND HAS BEEN USED FOR EPITOPE PREDICTION. HOWEVER, IN ITS PRESENT FORM THE SOFTWARE GENERALLY RESULTS IN A HIGH NUMBER OF PUTATIVE EPITOPES, AND MORE ACCURATE PREDICTION REQUIRES SUBSTANTIAL EXPERIMENTAL EFFORTS, E.G., BY SITE-DIRECTED MUTAGENESIS. WE WILL MODIFY PIPER TO MAXIMIZE THE INFORMATION AVAILABLE FROM THE DOCKING BY GENERATING A LARGE ENSEMBLE OF LOW ENERGY DOCKED STRUCTURES AND CALCULATING A CONTACT MAP RATHER THAN DISCRETE DOCKED STRUCTURES. THE NUMBER OF POTENTIAL EPITOPES WILL BE FURTHER REDUCED BY A TEMPLATE-BASED APPROACH BASED ON VECTOR CONTACT MAPS TO CHARACTERIZE ANTIBODY-ANTIGEN INTERFACES. WE ALSO EXPLORE PREDICTING THE EPITOPE BASED ON MODELS OF THE CDR REGIONS. GENERATING LARGE ENSEMBLES OF DOCKED STRUCTURES WITH A LARGE VARIETY OF CDR CONFORMATIONS WILL REDUCE THE SENSITIVITY OF THE METHOD TO INEVITABLE MODELING AND DOCKING UNCERTAINTY. BY INCREASING THE RELIABILITY OF THE PREDICTED EPITOPES, WE EXPECT TO REDUCE OR EVEN TO ELIMINATE THE NEED FOR MUTAGENESIS EXPERIMENTS. FINALLY, WE WILL DEVELOP A MACHINE- LEARNING ALGORITHM FOR THE MAPPING OF AMINO ACID COMPOSITION OF CDR REGIONS INTO EPITOPE COMPOSITION, A METHOD THAT CAN BE USED WHEN ONLY THE ANTIBODY SEQUENCE AVAILABLE AND STRUCTURE PREDICTION IS UNCERTAIN DUE TO THE LACK OF SUITABLE TEMPLATES.
$0
1/28/21
Not listed
SOFTWARE FOR ANTIBODY EPITOPE PREDICTION - ACCURATE EPITOPE PREDICTION IS IMPORTANT FOR THE DEVELOPMENT OF ANTIBODY-BASED THERAPIES. WHEN MULTIPLE NEW ANTIBODIES ARE DISCOVERED AGAINST THE WHOLE ANTIGEN, THEIR EPITOPES AND, THEREFORE, POTENTIAL NOVELTY AND MECHANISM OF ACTION ARE USUALLY UNKNOWN SITE-DIRECTED MUTAGENESIS, THE ROUTINE METHOD FOR EPITOPE MAPPING, REQUIRES TESTING A LARGE NUMBER OF MUTANTS SINCE ANY PART OF THE ANTIGEN CAN POTENTIALLY FORM AN EPITOPE THE GOAL OF THIS PROPOSAL IS DEVELOPING METHODOLOGY AND SOFTWARE FOR THE ACCURATE COMPUTATIONAL PREDICTION OF DISCONTINUOUS B-CELL EPITOPES BASED ON THE STRUCTURE OF AN ANTIGEN AND THE STRUCTURE OR SEQUENCE OF AN ANTIBODY. OUR STARTING POINT IS PIPER, A PROTEIN-PROTEIN DOCKING PROGRAM LICENSED BY ACPHARIS FROM BOSTON UNIVERSITY. PIPER IS THE DOCKING ENGINE IN THE SOFTWARE PACKAGES BIOLUMINATE BY SCHRODINGER AND THE CYRUSBENCH SUITE OF CYRUS BIOTECHNOLOGY, AS WELL AS IN THE PUBLIC SERVER CLUSPRO. PIPER HAS A SPECIAL OPTION FOR ANTIBODY-ANTIGEN DOCKING, AND HAS BEEN USED FOR EPITOPE PREDICTION. HOWEVER, IN ITS PRESENT FORM THE SOFTWARE GENERALLY RESULTS IN A HIGH NUMBER OF PUTATIVE EPITOPES, AND MORE ACCURATE PREDICTION REQUIRES SUBSTANTIAL EXPERIMENTAL EFFORTS, E.G., BY SITE-DIRECTED MUTAGENESIS. WE WILL MODIFY PIPER TO MAXIMIZE THE INFORMATION AVAILABLE FROM THE DOCKING BY GENERATING A LARGE ENSEMBLE OF LOW ENERGY DOCKED STRUCTURES AND CALCULATING A CONTACT MAP RATHER THAN DISCRETE DOCKED STRUCTURES. THE NUMBER OF POTENTIAL EPITOPES WILL BE FURTHER REDUCED BY A TEMPLATE-BASED APPROACH BASED ON VECTOR CONTACT MAPS TO CHARACTERIZE ANTIBODY-ANTIGEN INTERFACES. WE ALSO EXPLORE PREDICTING THE EPITOPE BASED ON MODELS OF THE CDR REGIONS. GENERATING LARGE ENSEMBLES OF DOCKED STRUCTURES WITH A LARGE VARIETY OF CDR CONFORMATIONS WILL REDUCE THE SENSITIVITY OF THE METHOD TO INEVITABLE MODELING AND DOCKING UNCERTAINTY. BY INCREASING THE RELIABILITY OF THE PREDICTED EPITOPES, WE EXPECT TO REDUCE OR EVEN TO ELIMINATE THE NEED FOR MUTAGENESIS EXPERIMENTS. FINALLY, WE WILL DEVELOP A MACHINE- LEARNING ALGORITHM FOR THE MAPPING OF AMINO ACID COMPOSITION OF CDR REGIONS INTO EPITOPE COMPOSITION, A METHOD THAT CAN BE USED WHEN ONLY THE ANTIBODY SEQUENCE AVAILABLE AND STRUCTURE PREDICTION IS UNCERTAIN DUE TO THE LACK OF SUITABLE TEMPLATES.
$0
1/28/21
Not listed
SOFTWARE FOR ANTIBODY EPITOPE PREDICTION
$150.0k
7/22/19